Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Employer
-
Field
-
. ISO 13485, ISO 14971, IEC 60601, UK MDR) is desirable, as well as experience of applying signal processing or machine learning methods to physiological or sensor data. Application details: Applications
-
near completion of) in Machine Learning or Maths. Informal enquiries may be addressed to [email protected] For more information about working at the Department, see www.eng.ox.ac.uk/about/work
-
An opportunity has arisen for a Research Fellow in Machine Cognition in UCL Linguistics, within the Division of Psychology and Language Sciences and Faculty of Brain Sciences. UCL is ranked eighth
-
and evaluation of the developed methods using relevant imaging datasets and downstream computer vision tasks. This appointment is subject to UCL Terms and Conditions of Service for Research and
-
are recruiting a Lecturer/Assistant Professor or Associate Professor who applies cutting-edge machine learning, artificial intelligence and related computational biology to fundamental biological problems. About
-
learning techniques pertaining to computational electromagnetics. If the successful candidate has not yet been awarded their PhD, appointment will be made as a Research Assistant (Grade 6B). Payment at Grade
-
matching, optimal transport or cell-cycle modelling. Key Responsibilities These include but are not limited to: Leading an independent research project in scientific machine learning and mechanistic
-
Evidence of research achievement at the very highest international level, including a strong record of publications in top-tier venues in AI/machine learning and evidence of significant influence
-
. Contribute to the ongoing development of VISIBLE as an AI-enabled platform for experimental biology. About you You will have: PhD in computer science, data science, machine learning, computational biology
-
Essential PhD in immunology, hematology, molecular biology, stem cell biology, gene therapy, or a related discipline, achieved as at the fund’s start date (September 7, 2026) Strong experience in CAR T-cell